Literature DB >> 34337686

Role of PTEN-less in cardiac injury, hypertrophy and regeneration.

Tian Liang1,2, Feng Gao1,2, Jinghai Chen3,4.   

Abstract

Cardiovascular diseases are the leading cause of death worldwide. Cardiomyocytes are capable of coordinated contractions, which are mainly responsible for pumping blood. When cardiac stress occurs, cardiomyocytes undergo transition from physiological homeostasis to hypertrophic growth, proliferation, or apoptosis. During these processes, many cellular factors and signaling pathways participate. PTEN is a ubiquitous dual-specificity phosphatase and functions by dephosphorylating target proteins or lipids, such as PIP3, a second messenger in the PI3K/AKT signaling pathway. Downregulation of PTEN expression or inhibiting its biologic activity improves heart function, promotes cardiomyocytes proliferation, reduces cardiac fibrosis as well as dilation, and inhibits apoptosis following ischemic stress such as myocardial infarction. Inactivation of PTEN exhibits a potentially beneficial therapeutic effects against cardiac diseases. In this review, we summarize various strategies for PTEN inactivation and highlight the roles of PTEN-less in regulating cardiomyocytes during cardiac development and stress responses.
© 2021. The Author(s).

Entities:  

Keywords:  Cardiac apoptosis; Cardiac hypertrophy; Cardiomyocytes proliferation; PTEN; Regeneration

Year:  2021        PMID: 34337686     DOI: 10.1186/s13619-021-00087-3

Source DB:  PubMed          Journal:  Cell Regen        ISSN: 2045-9769


  84 in total

1.  Heart regeneration: Past, present and future.

Authors:  Adriana Bastos Carvalho; Antonio Carlos Campos de Carvalho
Journal:  World J Cardiol       Date:  2010-05-26

2.  A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.

Authors:  Giuseppa Augello; Roberto Puleio; Maria Rita Emma; Antonella Cusimano; Guido R Loria; James A McCubrey; Giuseppe Montalto; Melchiorre Cervello
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.

Authors:  S A Backman; V Stambolic; A Suzuki; J Haight; A Elia; J Pretorius; M S Tsao; P Shannon; B Bolon; G O Ivy; T W Mak
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

4.  PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning.

Authors:  Zheqing Cai; Gregg L Semenza
Journal:  Circ Res       Date:  2005-11-10       Impact factor: 17.367

5.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

6.  Dynamics of Cell Generation and Turnover in the Human Heart.

Authors:  Olaf Bergmann; Sofia Zdunek; Anastasia Felker; Mehran Salehpour; Kanar Alkass; Samuel Bernard; Staffan L Sjostrom; Mirosława Szewczykowska; Teresa Jackowska; Cris Dos Remedios; Torsten Malm; Michaela Andrä; Ramadan Jashari; Jens R Nyengaard; Göran Possnert; Stefan Jovinge; Henrik Druid; Jonas Frisén
Journal:  Cell       Date:  2015-06-11       Impact factor: 41.582

7.  A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.

Authors:  Andrea Alimonti; Caterina Nardella; Zhenbang Chen; John G Clohessy; Arkaitz Carracedo; Lloyd C Trotman; Ke Cheng; Shohreh Varmeh; Sara C Kozma; George Thomas; Erika Rosivatz; Rudiger Woscholski; Francesco Cognetti; Howard I Scher; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

Review 8.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

9.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

View more
  5 in total

1.  miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer-Role of PTEN.

Authors:  Aleksandra Majewska; Klaudia Brodaczewska; Aleksandra Filipiak-Duliban; Arkadiusz Kajdasz; Claudine Kieda
Journal:  Biomolecules       Date:  2022-05-11

2.  Construction and Bioinformatics Analysis of circRNA-miRNA-mRNA Network in Acute Myocardial Infarction.

Authors:  Jin Zhou; Shaolin He; Boyuan Wang; Wenling Yang; Yuqi Zheng; Shijiu Jiang; Dazhu Li; Jibin Lin
Journal:  Front Genet       Date:  2022-03-29       Impact factor: 4.599

3.  Effect of Ghrelin Intervention on the Ras/ERK Pathway in the Regulation of Heart Failure by PTEN.

Authors:  Yong Zhao; Quan Sun; Zhenyu Xu; Meixiu Li; Guozhong Tian
Journal:  Comput Math Methods Med       Date:  2022-01-17       Impact factor: 2.238

4.  Downregulation of the Cd38-Cyclic ADP-Ribose Signaling in Cardiomyocytes by Intermittent Hypoxia via Pten Upregulation.

Authors:  Shin Takasawa; Mai Makino; Tomoko Uchiyama; Akiyo Yamauchi; Sumiyo Sakuramoto-Tsuchida; Asako Itaya-Hironaka; Yoshinori Takeda; Keito Asai; Ryogo Shobatake; Hiroyo Ota
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

Review 5.  Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics.

Authors:  Miyesaier Abudureyimu; Xuanming Luo; Xiang Wang; James R Sowers; Wenshuo Wang; Junbo Ge; Jun Ren; Yingmei Zhang
Journal:  J Mol Cell Biol       Date:  2022-09-12       Impact factor: 8.185

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.